These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11990779)

  • 1. OC144-093, a novel P glycoprotein inhibitor for the enhancement of anti-epileptic therapy.
    Newman MJ; Dixon R; Toyonaga B
    Novartis Found Symp; 2002; 243():213-26; discussion 226-30, 231-5. PubMed ID: 11990779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
    Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD
    Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug transporters in the epileptic brain.
    Löscher W
    Epilepsia; 2007; 48 Suppl 1():8-13. PubMed ID: 17316407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures.
    Volk HA; Löscher W
    Brain; 2005 Jun; 128(Pt 6):1358-68. PubMed ID: 15716304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats.
    van Vliet EA; van Schaik R; Edelbroek PM; Voskuyl RA; Redeker S; Aronica E; Wadman WJ; Gorter JA
    J Pharmacol Exp Ther; 2007 Jul; 322(1):141-7. PubMed ID: 17392402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats.
    van Vliet EA; Zibell G; Pekcec A; Schlichtiger J; Edelbroek PM; Holtman L; Aronica E; Gorter JA; Potschka H
    Neuropharmacology; 2010 Feb; 58(2):404-12. PubMed ID: 19786037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of dihydropyrroloquinolines that selectively antagonize P-glycoprotein.
    Lee BD; Li Z; French KJ; Zhuang Y; Xia Z; Smith CD
    J Med Chem; 2004 Mar; 47(6):1413-22. PubMed ID: 14998330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy.
    Brandt C; Bethmann K; Gastens AM; Löscher W
    Neurobiol Dis; 2006 Oct; 24(1):202-11. PubMed ID: 16928449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
    Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
    Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis.
    Kubota H; Ishihara H; Langmann T; Schmitz G; Stieger B; Wieser HG; Yonekawa Y; Frei K
    Epilepsy Res; 2006 Mar; 68(3):213-28. PubMed ID: 16361082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of antiepileptic drugs with human P-glycoprotein in vitro.
    Weiss J; Kerpen CJ; Lindenmaier H; Dormann SM; Haefeli WE
    J Pharmacol Exp Ther; 2003 Oct; 307(1):262-7. PubMed ID: 12954800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Several major antiepileptic drugs are substrates for human P-glycoprotein.
    Luna-Tortós C; Fedrowitz M; Löscher W
    Neuropharmacology; 2008 Dec; 55(8):1364-75. PubMed ID: 18824002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on pyrrolopyrimidines as selective inhibitors of multidrug-resistance-associated protein in multidrug resistance.
    Wang S; Folkes A; Chuckowree I; Cockcroft X; Sohal S; Miller W; Milton J; Wren SP; Vicker N; Depledge P; Scott J; Smith L; Jones H; Mistry P; Faint R; Thompson D; Cocks S
    J Med Chem; 2004 Mar; 47(6):1329-38. PubMed ID: 14998323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (+/-)-3'-O, 4'-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells.
    Shen X; Chen G; Zhu G; Fong WF
    Bioorg Med Chem; 2006 Nov; 14(21):7138-45. PubMed ID: 16875827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
    Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
    Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
    Mahar Doan KM; Humphreys JE; Webster LO; Wring SA; Shampine LJ; Serabjit-Singh CJ; Adkison KK; Polli JW
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1029-37. PubMed ID: 12438524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1.
    Xiao JJ; Foraker AB; Swaan PW; Liu S; Huang Y; Dai Z; Chen J; Sadée W; Byrd J; Marcucci G; Chan KK
    J Pharmacol Exp Ther; 2005 Apr; 313(1):268-76. PubMed ID: 15634944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.